Catalent, Inc.
Total Trades
127
Buys
2
Sells
73
Largest Trade
N/A
Insiders
25
Institutional Funds
1
Inst. Value
<$1K
Activist Filings
20
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Fasman Steven L | EVP & Chief Admin … | GRANT | N/A | 12K | — | Aug 3, 2023 |
| Fasman Steven L | EVP & Chief Admin … | SELL | $50K–$100K | 2K | $47.05 | Aug 3, 2023 |
| Boerman Manja | Pres. BioModalitie… | SELL | $50K–$100K | 1K | $49.86 | May 3, 2023 |
| Gargiulo Mario | SVP | SELL | $15K–$50K | 678 | $49.86 | May 3, 2023 |
| Hopson Ricky | Pres. Clinical Dev… | SELL | $15K–$50K | 643 | $49.36 | Jan 25, 2023 |
| Boerman Manja | Pres. BioModalitie… | SELL | $15K–$50K | 780 | $51.70 | Dec 7, 2022 |
| Grippo Michael J | SVP | SELL | $100K–$500K | 2K | $65.83 | Nov 2, 2022 |
| Hawkeswood Thomas W | Pres. Pharma Prod … | SELL | $50K–$100K | 930 | $77.46 | Oct 12, 2022 |
| Hopson Ricky | Pres. Clinical Dev… | SELL | $100K–$500K | 2K | $89.59 | Sep 2, 2022 |
| Riley Michael A. | Pres. Bio Product … | SELL | $100K–$500K | 2K | $104.07 | Aug 30, 2022 |
| Gunther Scott | SVP | SELL | $100K–$500K | 2K | $104.07 | Aug 30, 2022 |
| Schmidt Kay A | SVP | GRANT | N/A | 4K | — | Aug 27, 2022 |
| Schmidt Kay A | SVP | SELL | $100K–$500K | 1K | $103.04 | Aug 27, 2022 |
| Riley Michael A. | Pres. Bio Product … | GRANT | N/A | 4K | — | Aug 27, 2022 |
| Riley Michael A. | Pres. Bio Product … | SELL | $100K–$500K | 1K | $103.04 | Aug 27, 2022 |
| Pravda Ricardo | SVP & Chief HR Off… | GRANT | N/A | 5K | — | Aug 27, 2022 |
| Pravda Ricardo | SVP & Chief HR Off… | SELL | $100K–$500K | 2K | $103.04 | Aug 27, 2022 |
| Maselli Alessandro | President & CEO | GRANT | N/A | 11K | — | Aug 27, 2022 |
| Maselli Alessandro | President & CEO | SELL | $100K–$500K | 5K | $103.04 | Aug 27, 2022 |
| Hunt Patricia | Pres. Consumer Hea… | SELL | $15K–$50K | 339 | $103.04 | Aug 27, 2022 |
| Hunt Patricia | Pres. Consumer Hea… | GRANT | N/A | 949 | — | Aug 27, 2022 |
| Hopson Ricky | Pres. Clinical Dev… | SELL | $100K–$500K | 2K | $103.04 | Aug 27, 2022 |
| Hopson Ricky | Pres. Clinical Dev… | GRANT | N/A | 4K | — | Aug 27, 2022 |
| Hawkeswood Thomas W | Pres. Pharma Prod … | SELL | $50K–$100K | 671 | $103.04 | Aug 27, 2022 |
| Hawkeswood Thomas W | Pres. Pharma Prod … | GRANT | N/A | 1K | — | Aug 27, 2022 |
| Gunther Scott | SVP | SELL | $100K–$500K | 2K | $103.04 | Aug 27, 2022 |
| Gunther Scott | SVP | GRANT | N/A | 5K | — | Aug 27, 2022 |
| Grippo Michael J | SVP | GRANT | N/A | 5K | — | Aug 27, 2022 |
| Grippo Michael J | SVP | SELL | $100K–$500K | 2K | $103.04 | Aug 27, 2022 |
| Gennadios Aristippos | Group Pres. Pharma… | SELL | $100K–$500K | 2K | $103.04 | Aug 27, 2022 |
| Gennadios Aristippos | Group Pres. Pharma… | GRANT | N/A | 7K | — | Aug 27, 2022 |
| Gargiulo Mario | SVP Global Ops Bio… | GRANT | N/A | 3K | — | Aug 27, 2022 |
| Gargiulo Mario | SVP Global Ops Bio… | SELL | $100K–$500K | 2K | $103.04 | Aug 27, 2022 |
| Fasman Steven L | EVP & Chief Admin … | SELL | $100K–$500K | 5K | $103.04 | Aug 27, 2022 |
| Fasman Steven L | EVP & Chief Admin … | GRANT | N/A | 10K | — | Aug 27, 2022 |
| Chiminski John R | Executive Chair | SELL | $1M+ | 39K | $103.04 | Aug 27, 2022 |
| Chiminski John R | Executive Chair | GRANT | N/A | 99K | — | Aug 27, 2022 |
| Castellano Thomas P | CFO | SELL | $100K–$500K | 1K | $103.04 | Aug 27, 2022 |
| Castellano Thomas P | CFO | GRANT | N/A | 4K | — | Aug 27, 2022 |
| Carletti Lorenzo | SVP Global Ops Ph … | SELL | $100K–$500K | 1K | $103.04 | Aug 27, 2022 |
| Carletti Lorenzo | SVP Global Ops Ph … | GRANT | N/A | 2K | — | Aug 27, 2022 |
| Boerman Manja | Pres. BioModalitie… | SELL | $100K–$500K | 3K | $103.04 | Aug 27, 2022 |
| Boerman Manja | Pres. BioModalitie… | GRANT | N/A | 7K | — | Aug 27, 2022 |
| Arnold Jonathan | SVP & Chief Commer… | SELL | $15K–$50K | 384 | $103.04 | Aug 27, 2022 |
| Arnold Jonathan | SVP & Chief Commer… | GRANT | N/A | 7K | — | Aug 27, 2022 |
| Schmidt Kay A | SVP | SELL | $15K–$50K | 323 | $106.90 | Jul 29, 2022 |
| Schmidt Kay A | SVP | GRANT | N/A | 1K | — | Jul 29, 2022 |
| Pravda Ricardo | SVP & Chief HR Off… | SELL | $15K–$50K | 427 | $106.90 | Jul 29, 2022 |
| Pravda Ricardo | SVP & Chief HR Off… | GRANT | N/A | 1K | — | Jul 29, 2022 |
| Maselli Alessandro | President & CEO | SELL | $50K–$100K | 816 | $106.90 | Jul 29, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 14, 2024
0.6%
1.2M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Nov 14, 2024
0.1%
201K shares
Capital World Investors 95-1411037
SC 13G/A · Nov 13, 2024
3.5%
6.4M shares
Capital World Investors 95-1411037
SC 13G/A · May 10, 2024
5.3%
9.7M shares
SC 13G · Feb 14, 2024
6.4%
11.5M shares
T. Rowe Price Investment Management, Inc. 85-4328500
SC 13G/A · Feb 14, 2024
6.2%
11.2M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
11.2%
20.2M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 13, 2024
7.3%
13.2M shares
SC 13G/A · Feb 12, 2024
3.6%
6.5M shares
Capital World Investors 95-1411037
SC 13G/A · Feb 9, 2024
10.6%
19.1M shares
SC 13G/A · Jan 25, 2024
9.0%
16.2M shares
Capital World Investors 95-1411037
SC 13G/A · Oct 10, 2023
10.0%
18.0M shares
T. Rowe Price Investment Management, Inc. 85-4328500
SC 13G/A · Feb 14, 2023
9.2%
16.6M shares
Capital World Investors 95-1411037
SC 13G/A · Feb 13, 2023
7.7%
13.9M shares
SC 13G · Jan 27, 2023
6.2%
11.2M shares
T. Rowe Price Investment Management, Inc. 85-4328500
SC 13G · Oct 11, 2022
10.2%
18.4M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Aug 10, 2022
1.2%
2.2M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
10.8%
18.6M shares
Capital World Investors 95-1411037
SC 13G · Feb 11, 2022
6.2%
10.6M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 10, 2022
5.1%
8.8M shares